# Miyuki Matsukawa

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/miyuki-matsukawa/

## Facts

| Field | Value |
| --- | --- |
| Citations | 259 |
| Field | Diabetes Treatment and Management |
| h-index | 8 |
| i10-index | 7 |
| Last Known Institution | Otsuka (Japan) |
| OpenAlex ID | https://openalex.org/A5085600285 |
| Works | 18 |

## Researcher papers

- [Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus](https://scholariq.org/papers/associations-between-eating-habits-and-glycemic-control-and-obesity-in-japanese/)
- [Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet’s disease: a large-scale, long-term postmarketing surveillance in Japan](https://scholariq.org/papers/safety-and-efficacy-of-infliximab-in-the-treatment-of-refractory-uveoretinitis/)
- [Safety profiles and efficacy of infliximab therapy in Japanese patients with plaque psoriasis with or without psoriatic arthritis, pustular psoriasis or psoriatic erythroderma: Results from the prospective post‐marketing surveillance](https://scholariq.org/papers/safety-profiles-and-efficacy-of-infliximab-therapy-in-japanese-patients-with/)
- [Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease](https://scholariq.org/papers/real-world-safety-and-effectiveness-of-infliximab-in-pediatric-patients-with/)
- [Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan](https://scholariq.org/papers/long-term-real-world-safety-and-efficacy-of-teneligliptin-a-post-marketing/)
- [Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance](https://scholariq.org/papers/safety-and-efficacy-of-teneligliptin-in-patients-with-type-2-diabetes-mellitus/)
- [Safety and efficacy of long-term treatment with teneligliptin: Interim analysis of a post-marketing surveillance of more than 10,000 Japanese patients with type 2 diabetes mellitus](https://scholariq.org/papers/safety-and-efficacy-of-long-term-treatment-with-teneligliptin-interim-analysis/)
- [Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies](https://scholariq.org/papers/efficacy-and-safety-of-teneligliptin-40-mg-in-type-2-diabetes-a-pooled-analysis/)
- [Development of Soft, Sticky Itohiki-natto Manufactured for Senior Citizens](https://scholariq.org/papers/development-of-soft-sticky-itohiki-natto-manufactured-for-senior-citizens/)
- [Relationship of Eating Patterns and Metabolic Parameters, and Teneligliptin Treatment: Interim Results from Post-marketing Surveillance in Japanese Type 2 Diabetes Patients](https://scholariq.org/papers/relationship-of-eating-patterns-and-metabolic-parameters-and-teneligliptin/)
- [Quality of Life in Adults with Atopic Dermatitis in Relation to Disease Severity: Nationwide Data in Japan](https://scholariq.org/papers/quality-of-life-in-adults-with-atopic-dermatitis-in-relation-to-disease-severity/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)

## Researcher university

- [Otsuka (Japan)](https://scholariq.org/institutions/otsuka-japan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.